Investigative and Clinical Urology (Jul 2019)

Establishment of the Seoul National University Prospectively Enrolled Registry for Genitourinary Cancer (SUPER-GUC): A prospective, multidisciplinary, bio-bank linked cohort and research platform

  • Chang Wook Jeong,
  • Jungyo Suh,
  • Hyeong Dong Yuk,
  • Bum Sik Tae,
  • Miso Kim,
  • Bhumsuk Keam,
  • Jin Ho Kim,
  • Sang Youn Kim,
  • Jeong Yeon Cho,
  • Seung Hyup Kim,
  • Kyung Chul Moon,
  • Gi Jeong Cheon,
  • Ja Hyeon Ku,
  • Hyeon Hoe Kim,
  • Cheol Kwak

DOI
https://doi.org/10.4111/icu.2019.60.4.235
Journal volume & issue
Vol. 60, no. 4
pp. 235 – 243

Abstract

Read online

Purpose: To establish a prospective, comprehensive, multidisciplinary, bio-bank linked genitourinary cancer cohort based on standard real practice. Materials and Methods: We established the Seoul National University Prospectively Enrolled Registry for Genitourinary Cancer (SUPER-GUC), a prospective cohort clinical database and bio-specimen repository system for prostate cancer (SUPER-PC), renal cell carcinoma (SUPER-RCC), and urothelial cancer (SUPER-UC) at a high-volume, tertiary institution. Each cohort consists of several sub-cohorts based on treatment or disease status. Detailed longitudinal clinical information, and general and disease specific patient-reported outcomes are captured. We use the same evaluation format and questionnaires for all participating departments. Patients' blood, urine, tumor, and normal tissues are collected. The number of registered patients and their basic characteristics are summarized. For the surgical sub-cohort, study participation, bio-specimen, and tissue banking rates are analyzed. Results: Since March 2016, 11 sub-cohorts for all disease statuses have been opened, ranging from low-risk localized to metastatic disease. SUPER-PC, SUPER-RCC, and SUPER-UC enrolled 929, 796, and 1,221 patients, respectively. Study participation, bio-sampling, and fresh frozen tumor banking rates of surgical sub-cohorts were 89.0% to 93.1%, 91.2% to 99.1%, and 56.9% to 79.1%, respectively. Conclusions: SUPER-GUC is a study platform for comparative outcome, quality-of-life, and translational (genetics, biomarkers) research for genitourinary cancer.

Keywords